Nine Point Two Capital LLC Aurinia Pharmaceuticals Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 23,962 shares of AUPH stock, worth $191,696. This represents 0.09% of its overall portfolio holdings.
Number of Shares
23,962
Previous 23,962
-0.0%
Holding current value
$191,696
Previous $186,000
15.59%
% of portfolio
0.09%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
209Shares Held
58.2MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$74.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$65.6 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$57.8 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.8 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.14B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...